Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 3 | |
Outperform | 4 | |
Hold | 2 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 8 analysts offering 12 month price targets for Caribou Biosciences Inc have a median target of 13.50, with a high estimate of 30.00 and a low estimate of 3.00. The median estimate represents a 475.69% increase from the last price of 2.35.
High | 1,179.3% | 30.00 |
Med | 475.7% | 13.50 |
Low | 27.9% | 3.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 12, 2025.
Average growth rate | -56.18% |
Average growth rate | +21.64% |
More ▼
Revenue history & estimates in USD
Average growth rate | -28.91% |
Average growth rate | +96.61% |
More ▼